NDC 0135-0609-05 - PANADOL Extra Strength
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0135-0609
- Requested NDC
- 0135-0609-05
- Package NDCs from labels
- 0135-0609-01, 0135-0609-02, 0135-0609-03, 0135-0609-05, 0135-0609-04
- Manufacturer
- Haleon US Holdings LLC
- Effective date
- 2024-02-06
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| PANADOL Extra Strength - Haleon US Holdings LLC | Haleon US Holdings LLC | 2024-02-06 | HUMAN OTC DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| NDC | Related label |
|---|---|
| 0135-0609-01 | Drug Facts |
| 0135-0609-02 | Drug Facts |
| 0135-0609-03 | Drug Facts |
| 0135-0609-04 | Drug Facts |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0135-0609-01 | PANADOLExtra Strength | 24 in 1 BOTTLE | TABLET, FILM COATED | 24 | 7 | |
| 0135-0609-01 | PANADOLExtra Strength | 1 in 1 CARTON | TABLET, FILM COATED | 1 | 7 | |
| 0135-0609-02 | PANADOLExtra Strength | 50 in 1 BOTTLE | TABLET, FILM COATED | 50 | 7 | |
| 0135-0609-02 | PANADOLExtra Strength | 1 in 1 CARTON | TABLET, FILM COATED | 1 | 7 | |
| 0135-0609-03 | PANADOLExtra Strength | 100 in 1 BOTTLE | TABLET, FILM COATED | 100 | 7 | |
| 0135-0609-03 | PANADOLExtra Strength | 1 in 1 CARTON | TABLET, FILM COATED | 1 | 7 | |
| 0135-0609-04 | PANADOLExtra Strength | 50 in 1 CARTON | TABLET, FILM COATED | 50 | 7 | |
| 0135-0609-05 | PANADOLExtra Strength | 2 in 1 PACKET | TABLET, FILM COATED | 2 | 7 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0135-0609-01 | EA - Each | 0135-0609 | fe1f0735-9843-4fe3-bb42-0a2256c3b2c6 | 1 | 2022-12-07 |
| 0135-0609-02 | EA - Each | 0135-0609 | 2e35bea5-0a22-4410-ac97-e2465812c2d8 | 1 | 2022-12-07 |
| 0135-0609-03 | EA - Each | 0135-0609 | a22d623d-3cc7-4af6-a98a-fbe4fceff390 | 1 | 2022-12-07 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Vicks NyQuil SINUS PAIN and HEADACHE | ACETAMINOPHEN, DOXYLAMINE SUCCINATE | The Procter & Gamble Manufacturing Company | 4c4ca296-ea6c-1f19-e063-6294a90a8161 | 2026-10-09 | Warnings | 362O9ITL9D |
| Vicks Formula 44 DM Painful Cough and Sore Throat | ACETAMINOPHEN, DEXTROMETHORPHAN HBR | The Procter & Gamble Manufacturing Company | d536f159-304f-4759-be14-0e4895777c97 | 2026-10-09 | Warnings | 362O9ITL9D |
| Vicks Sinex Severe PAIN, MUCUS and CHEST CONGESTION | ACETAMINOPHEN, GUAIFENESIN | The Procter & Gamble Manufacturing Company | 5605aab6-6074-0a3b-e063-6294a90a49a2 | 2026-10-09 | Warnings | 362O9ITL9D |
| infants pain fever | ACETAMINOPHEN | H E B | 1da89528-f658-4103-8041-cee4c775d73f | 2026-10-09 | Warnings | M013 362O9ITL9D |
| Topcare Migraine Relief | ACETAMINOPHEN, ASPIRIN, CAFFEINE | Topco Associates LLC | a2a9fbec-639f-4002-aa34-51b4563fc38e | 2026-10-09 | Warnings | 362O9ITL9D |
| aspirin | ASPIRIN | Meijer Distribution Inc | 338aea3b-a38f-424f-9006-3ede3825bf90 | 2026-10-09 | Warnings | M013 |
| infants pain fever | ACETAMINOPHEN | H E B | ab8ecc76-9621-4acc-b59b-fcf6cb2e52ef | 2026-10-09 | Warnings | M013 362O9ITL9D |
| Complete Cold Relief | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCL | Belmora LLC | a81fc021-9a9f-4cec-a1a6-73e3f983b78d | 2026-10-08 | Warnings | 362O9ITL9D |
| butalbital and acetaminophen | BUTALBITAL AND ACETAMINOPHEN | Granules Pharmaceuticals Inc. | 2091c292-b77b-4ce6-8bba-436c74eee3d7 | 2026-10-08 | Boxed warning, Warnings, Adverse reactions | 362O9ITL9D |
| Acetaminophen and Ibuprofen | ACETAMINOPHEN AND IBUPROFEN | Granules Pharmaceuticals Inc. | 0f8b9524-8fe3-47cf-bacd-93047442d90d | 2026-10-08 | Warnings | 362O9ITL9D |
| ACETAMINOPHEN | ACETAMINOPHEN | Granules Pharmaceuticals Inc. | d5352861-6926-f1b0-e053-2a95a90a7d66 | 2026-10-08 | Warnings | 362O9ITL9D |
| ACETAMINOPHEN | ACETAMINOPHEN | Granules Pharmaceuticals Inc. | d5d49146-665e-4a93-e053-2995a90aca59 | 2026-10-08 | Warnings | M013 198440 362O9ITL9D |
| Acetaminophen and Ibuprofen Back Pain | ACETAMINOPHEN AND IBUPROFEN | Granules Pharmaceuticals Inc. | 32562aa1-f44b-649e-e063-6394a90a47c8 | 2026-10-08 | Warnings | 362O9ITL9D |
| Oxycodone and Acetaminophen | OXYCODONE AND ACETAMINOPHEN | Granules Pharmaceuticals Inc. | cc966d57-7cdc-4de3-bbcf-718e2fce9cb7 | 2026-10-08 | Boxed warning, Warnings, Adverse reactions | 362O9ITL9D |
| Hydrocodone Bitartrate and Acetaminophen | HYDROCODONE BITARTRATE AND ACETAMINOPHEN | Granules Pharmaceuticals Inc. | 136bbd47-7a54-493f-9158-a84d39221d6c | 2026-10-08 | Boxed warning, Warnings, Adverse reactions | 362O9ITL9D |
| Aspirin | ASPIRIN | PD-Rx Pharmaceuticals, Inc. | 98c30922-c48c-471a-a72e-50020a11da98 | 2026-10-08 | Warnings | M013 |
| Mejoralito | ACETAMINOPHEN | OPMX | 5a963a92-e29d-05ba-e063-6394a90a3a47 | 2026-10-08 | Warnings | M013 362O9ITL9D |
| Pentrexcilina | ACETAMINOPHEN | OPMX LLC | 5a98e123-8e28-6732-e063-6394a90a010c | 2026-10-08 | Warnings | M013 362O9ITL9D |
| Tramadol Hydrochloride and Acetaminophen | TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN | Preferred Pharmaceuticals Inc. | 96094578-5348-4955-8e91-1c9163315d5a | 2026-10-07 | Boxed warning, Warnings, Adverse reactions | 362O9ITL9D |
| aspirin | ASPIRIN | CVS Pharmacy | bd11081f-c5d1-4c98-8f5a-4c45269df79b | 2026-10-07 | Warnings | M013 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.